deutraMed™ is attending the 2024 Electronic Specialty Gas & Systems (ESGS) Conference at Wild Horse Pass in Chandler, Arizona. Steven Bovair, Sales Manager, will represent the company at the annual… Continue reading →
News
Justin Guo Wins deutraMed Chemistry and Innovation Award at Canada-Wide Science Fair
deutraMed Inc. congratulates Justin Guo, a student from the Greater Vancouver area, for winning the deutraMed-sponsored Chemistry and Innovation Award at the 2024 Canada-Wide Science Fair (CWSF). Guo won the… Continue reading →
deutraMed Biomolecule Stabilization Technology Platform Earns Additional Patent, Opening Door to New Biomedical Applications
Patented new value-added method improves mRNA stability during synthesis and storage (Collingwood, Ont., July 19, 2023) – deutraMed Inc. today announced that its Biomolecule Stabilization Technology Platform has been awarded… Continue reading →
deutraMed to Attend mRNA-Based Therapeutics Summit; Chief Scientist to Present Research Findings
July 26-28, 2023 Boston, MA deutraMed Managing Director Lisa Stuart and the company’s Chief Scientist, Dr. Pavel Gris, will attend the July 26-28, 2023 mRNA-Based Therapeutics Summit in Boston. Dr…. Continue reading →
Hudson Gibbs Wins deutraMed Chemistry and Innovation Award at Canada-Wide Science Fair
(Collingwood, Ont., May 24, 2023) – deutraMed Inc., a breakthrough deuterium science and innovation company, congratulates Hudson Gibbs, a Grade 7 student from Cornwall, Ontario, for winning the deutraMed-sponsored Chemistry… Continue reading →
KEY Recognized by Sustainable Development Technology Canada as a “Canadian Sustainability Changemaker” for Second Year
Yearly distinction honours 10 companies for homegrown, sustainable innovation OWEN SOUND, Ontario (May 8, 2023) – Sustainable Development Technology Canada (SDTC) has recognized Key DH Technologies Inc. (KEY) as a… Continue reading →
deutraMed to Attend mRNA-Based Therapeutics Summit Europe
deutraMed to Attend mRNA-Based Therapeutics Summit Europe January 24-26, 2023 Berlin, Germany deutraMed Chief Scientist Dr. Pavel Gris will attend the mRNA-Based Therapeutics Summit Europe, to be held in Berlin,… Continue reading →
Electronic Specialty Gas (ESG) Conference and Business Interface Conference (BIC) hosted by Linx Consulting
deutraMed to Attend Electronic Specialty Gas Conference October 19-21, 2022 Chandler, Arizona deutraMed will attend the Electronic Specialty Gas Conference and Business Interface Conference to be held October 19 to… Continue reading →
New Brunswick Student Wins deutraMed Chemistry and Innovation Award at Canada-Wide Science Fair
(Collingwood, Ont., May 31, 2022) – deutraMed Inc., a breakthrough deuterium science and innovation company, congratulates Grade 8 student Kevin Cornell of Riverview, New Brunswick for winning the deutraMed-sponsored Chemistry… Continue reading →
deutraMed to Attend DCAT Week July 12-16
deutraMed Inc. is excited to attend DCAT Week, the premier annual event for companies engaged in the Bio/Pharmaceutical manufacturing value chain. The event, hosted virtually this year by the Drug,… Continue reading →